Fulgent Genetics (FLGT) President/COO sells shares for tax withholding
Rhea-AI Filing Summary
Fulgent Genetics (FLGT) insider sale by President & COO: On 08/27/2025, reporting person Xie Jian sold 1,199 shares of Fulgent common stock at a weighted-average price of $21.4847 to satisfy tax withholding from restricted stock units that vested from a Feb 26, 2024 RSU grant. After the sale, Mr. Xie beneficially owns 365,249 shares directly and 220,816 shares indirectly through The Hsieh Family Dynasty Trust (where he serves on the investment committee and disclaims beneficial interest except for any pecuniary interest). The Form 4 reports the sale as a routine, nondiscretionary transaction to cover tax obligations rather than an open-market cash-raising sale.
Positive
- Sale was for tax withholding on vested RSUs, indicating a non-discretionary, administrative reason for the transaction rather than a targeted cash sale.
- Significant residual ownership retained: 365,249 shares directly and 220,816 shares indirectly, showing continued substantial alignment with shareholders.
Negative
- None.
Insights
TL;DR: Routine RSU tax-withholding sale; small relative impact on insider stake and company float.
The sale of 1,199 shares at a weighted-average price of $21.4847 was executed to satisfy tax withholding associated with vested RSUs from a prior grant. Compared with the combined reported beneficial ownership of 586,065 shares (365,249 direct plus 220,816 indirect), the disposed amount is immaterial and unlikely to change market perception or signal major insider-led liquidity. No options, derivative exercises, or additional compensatory grants are reported here; this appears strictly administrative.
TL;DR: Transaction consistent with common tax-withholding practice; governance disclosure is complete and standard.
The Form 4 explains that shares were sold to cover tax obligations from vested restricted stock units, and it identifies the indirect holdings via a family trust where the reporting person serves on the investment committee. The reporting person disclaims beneficial interest except for pecuniary interest, which is appropriately disclosed. The description and price range disclosure meet typical SEC Form 4 transparency expectations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,199 | $21.4847 | $26K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. The shares were sold in multiple transactions at prices ranging from $21.28 to $21.66, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
